Roles & Responsibilities of the Research Team

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Roles & Responsibilities of the Research Team"

Transcription

1 Roles & Responsibilities of the Research Team Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group

2 Introduction All staff involved in clinical research must adhere to the regulations and understand the guidelines that govern clinical research. This module will provide an overview of the roles and responsibilities of the research team and other staff including: Investigator, Clinical Trial Nurse (CTN), Clinical Data Manager, Staff Nurse, and Pharmacist. At the conclusion of this module, you will be able to: Describe the role and responsibilities of the Investigator as described by OHRP, FDA, and ICH. Describe the role and responsibilities of the CTN. Describe the role and responsibilities of the Clinical Data Manager. Describe the role and responsibilities of the Staff Nurse. Describe the role and responsibilities of the Pharmacist.

3 OHRP s Use of Investigator OHRP interprets an investigator to be any individual who is involved in conducting human subjects research studies. Such involvement would include: obtaining information about living individuals by intervening or interacting with them for research purposes; obtaining identifiable private information about living individuals for research purposes; obtaining the voluntary informed consent of individuals to be subjects in research; and studying, interpreting, or analyzing identifiable private information or data for research purposes.

4 OHRP s Use of Investigator (continued) Investigators can include physicians, scientists, nurses, administrative staff, teachers, and students, among others. With multiple investigators, one investigator is designated the principal investigator with overall responsibilities for the study. The next several pages will review OHRP s current thinking on the role of the investigator. To learn more, review OHRP s Investigator Responsibility Frequently Asked Questions

5 Investigator Responsibilities Design and implement ethical research, consistent with three ethical principles delineated in the Belmont report Comply with all applicable federal regulations impacting the protection of human subjects Ensure that all research involving human subjects is submitted to and approved by the appropriate institutional review board

6 Investigator Responsibilities Comply with all applicable IRB policies, procedures, decisions, conditions, and requirements Implement research as approved and obtain prior IRB approval for changes Obtain informed consent and assent in accord with federal regulations and as approved by the IRB Document informed consent and assent in accord with federal regulations and as approved by the IRB

7 Investigator Responsibilities Report progress of approved research to the IRB, as often and in the manner prescribed by the IRB Report to the IRB any injuries, adverse events, or other unanticipated problems involving risks to subjects or others Retain signed consent documents and IRB research records for at least 3 years past completion of the research activity

8 FDA and the Role of the Investigator FDA defines the responsibilities of the Investigator when conducting FDA regulated research. All Investigators should refer to 21 CFR Parts 11, 50, 54, 56, 312, and 812 for a more comprehensive listing of FDA's requirements. The Investigator is the one who has the overall responsibility for the conduct of the clinical trial and is often referred to as the PI in the protocol document as Other Investigators are referred to as Subinvestigators by the FDA or in the NIH community an Associate Investigator (AIs).

9 Role of the Investigator: Drugs or Biologics An investigator s responsibilities in conducting clinical investigations of drugs or biologics are provided in 21 CFR Part 312 Many of these responsibilities are included in the required investigator s signed statement, Form FDA-1572 Page 2, Section 9 lists the commitments of the Investigator which appear on the next several slides

10 Investigator Commitments Conduct study in accordance with the relevant, current protocol and will only make changes in a protocol after notifying the sponsor, except when necessary to protect the safety, right, or welfare of subjects Personally conduct or supervise the described investigation

11 Investigator Commitments Inform any patients, or any persons used as controls, that the drugs are being used for investigational purposed and ensure requirement relating to obtaining informed consent in 21 CFR Part 50 and IRB review and approval in 21 CFT Part 56 are met Agree to report to sponsor adverse experiences that occur in the course of the investigation in accordance with 21 CFR

12 Investigator Commitments Read and understand the information in the investigator's brochure, including the potential risks and side effects of the drug Agree to ensure all associates, colleagues, and employees assisting in the conduct of the study are informed about their obligations in meeting the previous commitments

13 Investigator Commitments Maintain adequate and accurate records in accordance with 21 CFR and to make those records available for inspection in accordance with CFR Ensure that an IRB that complies with the requirements of 21 CFR Part 56 will be responsible for the initial and continuing review and approval of the clinical investigation Promptly report to the IRB all changes in research activity and all unanticipated problems involving risks to human subjects or others. Make no changes in the research w/o IRB approval expect where necessary to eliminate apparent immediate hazard to human subjects.

14 Investigator Commitments Comply with all other requirements regarding the obligation of clinical investigators and all other pertinent requirements in 21 CFR Part 312

15 Form 1572 Form 1572 is updated as needed There is one Form 1572 per study Exception: CTEP-sponsored trials have 1 form per investigator and must be updated at least annually. See their website for more information about Investigator registration for CTEPsponsored trials. All copies of the Form 1572 are to be maintained in the regulatory binder. To learn more, review FDA s 2010 Information Sheet Guidance for Sponsors, Clinical Investigators, and IRBs: Frequently Asked Questions Statement of Investigator (Form FDA 1572)

16 Role of the Investigator: Devices An investigator s responsibilities in conducting clinical investigations of a medical device are provided in 21 CFR Part 812, including the requirement that there be a signed agreement between the investigator and sponsor (see 21 CFR (c)(4) and ). Device regulations do not require the use of a specific form for an investigator s statement.

17 FDA Guidance The following FDA guidance document provides an overview of the responsibilities of a person who conducts a clinical investigation of a drug, biological product, or medical device (an investigator as defined in 21 CFR 312.3(b) and 21 CFR 812.3(i)). Investigator Responsibilities Protecting the Rights, Safety, and Welfare of Study Subjects This guidance provides information for the Investigator on: Supervisory activities associated with the conduct of a clinical trial including: What is appropriate delegation of study-related tasks What is adequate training What is adequate supervision of the conduct of ongoing clinical trial What are Investigator's responsibilities for oversight of other parties involved in the conduct of a clinical trial? Protecting the rights, safety, and welfare of study subjects Reasonable medical care Reasonable access to medical care Protocol violations that present unreasonable risk ALL research team members should review this document.

18 International Conference on Harmonisation (ICH) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use is an agreement between the European Union, Japan and the United States to harmonize different regional requirements for registration of pharmaceutical drug products Unique joint effort by regulators and associated pharmaceutical industry trade associations ICH guidelines have been adopted as law in several countries, but are only used as guidance for the U.S. Food and Drug Administration

19 International Conference on Harmonisation (ICH) Guidances 4 major categories of standards are: Quality guidelines chemical and pharmaceutical Quality Assurance Safety guidelines in vitro and in vivo pre-clinical studies Efficacy guidelines E1-E2F: Clinical safety E6: Good Clinical Practice (GCP) Guidelines Multidisciplinary guidelines cross-cutting topics that do not fit into one of the above categories

20 E6: Good Clinical Practice (GCP) Guidelines This document: Describes the responsibilities and expectations of all participants in the conduct of clinical trials, including investigators, monitors, sponsors and IRBs Covers aspects of monitoring, reporting and archiving in clinical trials Describes the essential documents that are to be maintained by the site and the sponsor The next several pages provide a summary of the Investigator s responsibilities as described in E6 Section 4.

21 E6: Investigator Qualifications & Agreements The Investigator should: Be qualified (documented) by education, training & experience to assume responsibility for proper trial conduct Be familiar with the appropriate use of the investigational product, IB, and other information provided by sponsor Be aware of, & should comply with, GCP and the applicable regulatory requirements Permit monitoring, auditing and inspection Delegate duties to appropriately qualified persons

22 E6: Adequate Resources The Investigator should: Demonstrate adequate potential for recruitment Have sufficient time for trial conduct and completion Have adequate staff and facilities to conduct the trial Ensure training to staff

23 E6: Medical Care of Trial Subjects The Investigator should: Ensure that qualified physician investigators/sub investigators for the trial, should be responsible for all trial related medical decisions Adequate medical care during and after trail participation Make reasonable efforts ascertaining for premature withdrawal from trial Inform subject's primary physician about the subject's participation in the trial if the subject has a primary physician and if the subject agrees to the primary physician being informed.

24 E6: Communication with IRB The Investigator should: Seek written & dated approval for trial protocol, informed consent document, recruitment procedures, etc. prior to trial initiation Provide latest copies of Investigator Brochure (IB) to IRB Provide all relevant documents for review during trial

25 E6: Compliance with Protocol The Investigator should: Conduct trial in accordance with the protocol version agreed & documented by the sponsor, IRB and regulatory authority Ensure that no changes are allowed in the protocol except in case of immediate hazard to the patient

26 E6: Investigational Product The Investigator: Is responsible for investigational product accountability at the site May be assigned to pharmacist/individual Ensure that investigational product is stored as specified by sponsor or regulatory authority Ensure that the investigational product is used only in accordance with the protocol

27 E6: Randomization Procedures and Unblinding The Investigator: Should follow the trial s randomization procedure Report any premature unblinding to be explained to sponsor

28 E6: Informed Consent.. The Investigator should: Comply with regulatory requirement, GCP and ethical principles Document communication of revised consent document to IRB and patient Not influence or coerce subject to participate Ensure that the subject or their legal representative is fully informed in their own language Review Subject's responsibilities as part of the informed consent process

29 E6: Informed Consent The Investigator should: Ensure that the informed consent document does not contain technical language Allow ample time for the consent process and opportunity for exchange of information or subject questions Provide an impartial witness for illiterate patients Provide the Subject with a copy of the signed and dated Informed Consent Document

30 E6: Records and Reports The Investigator: Should ensure accuracy, completeness, legibility and timeliness of data to sponsor in CRF Ensure corrections on a CRF be signed and dated Should maintain trial related documents Ensure all financial agreements are in place prior to subject enrollment Provide access to records by monitor, regulatory agency or auditors Submit progress reports to IRB

31 E6: Safety Reporting The Investigator should: Report all serious adverse events, including deaths, to sponsor and IRB/regulatory agency as per SOPs See Adverse Event Module for more information on adverse event reporting

32 E6: Premature Termination of Trial The Investigator should: Inform subjects Assure therapy and follow up Inform sponsor, IRB, and other regulatory authorities as per SOPs

33 E6: Final Report Upon completion of the study, the Investigator should provide the IRB and other regulatory authorities with a summary of the trial s outcome

34 Sub-Investigator The definition of "sub-investigator" in FDA's official guidance, the "ICH E-6 Good Clinical Practice: Consolidated Guidance," states: "Any individual member of the clinical trial team designated and supervised by the investigator at a trial site to perform critical trial-related procedures and//or to make important trial-related decisions (e.g., associates, residents, research fellows)." It's important to recognize that any study staff who "make direct and significant contribution to the data" are considered "sub-investigators" which means they would also need to be listed in block #6 of the Form FDA This may include the CTN.

35 Nurses and Clinical Research Nurses involved in clinical research continue to serve as advocates for their patients. However, the now take on 2 additional advocate roles: Subject advocate Protocol advocate The trick is learning how to balance all 3 advocacy roles. Nurses may play a role in study coordination or care for patients on a clinical trial or do both.

36 Clinical Trials Nurse As defined in the ONS CTN competencies, the CTN demonstrates critical thinking and implementation of the nursing process, thus providing leadership in the conduct of clinical trials, improving outcomes for patients, and enhancing study integrity. This is accomplished through competent practice in the following functional areas : Protocol compliance Clinical Trials Related Communication Informed Consent Process Management of Clinical Trial Patients Documentation Patient Recruitment Ethical Issues Professional Development The next several pages will highlight these competencies.

37 Protocol Compliance Adheres to current regulations, guidance, and policies that affect research at the institutional, state, federal, and international levels. Complies with the processes and procedures required by different types of sponsors (e.g., private industry, National Cancer Institute Cancer Therapy Evaluation Program, investigator-initiated). Ensures security of research data and personal health information. Participates in discussions regarding feasibility of protocol implementation based on knowledge of institutional capabilities and limitations, therapy, or population of interest. Collaborates with the research team to implement procedures for maintaining patient study participation from enrollment through completion.

38 Protocol Compliance Participates in providing timely, informative, and accurate communication to the IRB as required. Facilitates and participates in the preparation for and implementation of scheduled and unscheduled meetings with external and internal monitors and auditors (e.g., sponsors, FDA, IRB, QA). Ensures validity of research results by ensuring timely, accurate, and complete data documentation, reporting deviations, violations, and serious adverse events. Collaborates with principal investigator, pharmacy, and other appropriate personnel to ensure proper use of and accountability for experimental devices or drugs as indicated.

39 Clinical Trials Related Communication Ensures ongoing formal and informal communication regarding clinical trials with team members. Provides general clinical research as well as trialspecific information to research, clinical, and other organizational staff. Develops relationships with referring physicians, clinical staff, and ancillary departments to facilitate compliance with and accrual to clinical trials. Participates in study initiation meetings. Provides education related to clinical trials to patients and their significant others. Advocates for the safety and care of clinical trial patients as well as for the promotion and integrity of the clinical trial

40 Informed Consent Process Ensures the initial and ongoing consent process is performed and documented in compliance with FDA, International Conference on Harmonization Good Clinical Practice (GCP), institutional, sponsor, IRB, and other applicable regulations, guidances, and policies. Participates in the education of clinical trial patients about their clinical trial and significant new information that is forthcoming during or after the conduct of the trial. Assesses for barriers to effective informed consent discussions and implements plans to overcome them.

41 Management of Clinical Trial Patients Collaborates with the investigator to ascertain study patient eligibility for a clinical trial, including documentation of criteria specified in the protocol. Ensures adherence to the protocol schedule of events and other requirements. Ensures scheduling of all procedures required to assess for adverse events and disease response to the study intervention. Ensures the successful completion of correlative components of the clinical trial (e.g., pharmacokinetic, pharmacoeconomic, and quality-of-life studies). Assesses patients for trial-related and non trial-related symptoms and ensures evidence-based symptom management while maintaining trial compliance.

42 Management of Clinical Trial Patients In collaboration with the investigator, assesses patients for adverse events and then documents and reports these findings per the protocol, sponsor, IRB, FDA, and OBA regulations. Utilizes adverse event assessment data and clinical judgment to determine if a dose-limiting toxicity has occurred or if any treatment schedule or drug dose modifications are necessary and communicates findings to the study team and sponsors. Evaluates disease response results and physical assessment data in conjunction with the principal investigator to determine response per the protocol. Supports and evaluates patient adherence to the protocol by utilizing various methods to assist with documentation, patient education, and study agent return. Identifies vulnerable patients who require increased nursing assessment and management in addition to the clinical trial requirements.

43 Documentation Complies with regulations, institutional policies, and sponsor requirements governing source data and documentation. Documents assessment, management, and evaluation in source documents for patients on clinical trials as appropriate to the protocol and role. Educates research and clinical team members regarding appropriate and accurate source documentation for participants in clinical trials. Ensures that relevant data from the source document are abstracted and recorded in the clinical trial case report forms and that every data point can be verified within the source document.

44 Documentation Follows appropriate guidelines in making corrections to data entry in clinical records and case report forms as recommended by good clinical practices, standards, or institutional procedures. Ensures that all regulatory documents are processed and maintained per institution, IRB, and GCP. Demonstrates proficiency in the use of clinical and research-related computer programs.

45 Patient Recruitment Assists in implementation of recruitment plans to identify and assess individuals who might be eligible for clinical trials, taking into consideration the study entry criteria, required procedures, and other potential factors. Identifies and develops processes to overcome barriers to recruitment related to patient demographic factors, underserved populations, and healthcare system influences. Identifies institutional or community-based resources or groups that can assist in achieving recruitment goals

46 Ethics Advocates for ethical care of clinical trial patients and the conduct of clinical trials in accordance with standards of nursing practice. Promotes ongoing compliance with key ethical concepts by the research team, including informed consent, documentation, respect for persons, beneficence, and justice. Ensures that members of vulnerable populations enrolled in clinical trials are identified and that their rights are addressed. Identifies and follows institutional procedures to report any falsification of data or scientific misconduct.

47 Financial Implications Describes the key components included in study budgets and institutional resources for budget details. Confers with the principal investigator or finance personnel when protocol revisions will affect the costs of protocol management. Identifies routine care versus research-related costs, the financial impact on patients, and any need for financial counseling. Ensures and tracks submission of specified items (e.g., completed case report forms, specimens) to facilitate timely recovery of protocol-related activity costs. Ensures that stipends to patients for protocol-related activities are disclosed to the IRB during approval of the consent form.

48 Professional Development Participates in educational opportunities to increase knowledge about clinical trials, regulations and guidance, and the role of the CTN. Seeks resources on an ongoing basis that provide oncology treatment and nursing practice updates, such as through professional mentoring and meetings, journals, and Web sites.

49 Clinical Data Manager (CDM) Individual responsible for some or all activities related to Clinical Data Management: Data acquisition/collection Data abstraction/extraction Data processing/coding Data analysis Data transmission Data storage Data privacy Data QA Clinical data management is a multi-disciplinary activity that includes: Investigators CTNs Clinical data managers Support personnel Biostatisticians Database programmers

50 CDM Responsibilities Collects source documents needed for data abstraction Abstracts research data from patient s medical record/source documents to the case report form (paper or electronic) Enters data into database(s)

51 CDM Responsibilities Conducts self-audits to ensure data quality Manages protocol related data (i.e.: understanding what forms are still outstanding and what documentation is missing) Understands how CRFs are developed

52 CDM Responsibilities Understands the various databases used and how to resolve problems associated with the different systems Provides periodic reports from database Helps to prepare for audits/monitoring visits

53 Study Subject s Responsibilities The study subject has responsibilities as an integral member of clinical research. Their role needs to be reinforced as part of the informed consent process. Roles include: Adhering to protocol specific schedule of events Timely notification to the research staff including: Adverse events Changes in concomitant medications Inability to comply with protocol criteria (e.g.: exclusionary meds, keeping appointments, patient diaries, etc.) Change in status (e.g.: new phone #, adverse event, etc.) in a timely manner

54 Staff Nurse Provides direct patient care including treatment and patient education Adheres to protocol Documents all patient encounters in the medical record Collects specimen as per protocol Informs PI/CTN of patient or protocol related issues/concerns

55 Pharmacist Though the PI is ultimately accountable for drug accountability, this is often delegated to a pharmacist: Prepares drugs as per protocol Stores investigational products as per protocol For multiple studies using same IND agent, needs to provide separate/distinct storage in pharmacy Maintains accurate drug accountability records Receipts of drug shipment/invoices Drug accountability record form (DARF)

56 Example of a DARF

57 Helpful Hints: Know Your Protocols Eligibility criteria Drug preparation & administration Schema, requirements, follow-up PKs, research tests, restaging, drug return Dose limiting toxicity and/or dose modifications Reporting requirements Results (responses, toxicities)

58 Helpful Hints: Know the Disease Etiology Epidemiology Signs and Symptoms Screening and Diagnosis Pathology Grading Disease Staging Treatment Options What is standard therapy? Disease Trajectory Clinical Trials elsewhere for the same disease

59 Regardless of Your Role: Be Your Own Best Advocate Protect your time & get organized Learn as much as you can about: clinical trials oncology your particular drug(s) your database/software programs Know how/where to get training & do it Join a professional organization & get involved Teach something new & you will learn Teach someone new & you will grow

60 Module Evaluation The CTN SIG would greatly appreciate your feedback on this learning module. Please complete the evaluation form and fax to Elizabeth Ness at

Roles & Responsibilities of the Sponsor

Roles & Responsibilities of the Sponsor Roles & Responsibilities of the Sponsor Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Objectives Funding for clinical research comes from

More information

12.0 Investigator Responsibilities

12.0 Investigator Responsibilities v. 5.13.13 12.0 Investigator Responsibilities 12.1 Policy Investigators are ultimately responsible for the conduct of research. Research must be conducted according to the signed Investigator statement,

More information

GOOD CLINICAL PRACTICE: CONSOLIDATED GUIDELINE

GOOD CLINICAL PRACTICE: CONSOLIDATED GUIDELINE ICH E6 GCP: Consolidated Guideline: Investigator 1/7 Institutional Review Board Services ICH HARMONIZED TRIPARTITE GUIDELINE E6: GOOD CLINICAL PRACTICE: CONSOLIDATED GUIDELINE 4. INVESTIGATOR 4.1 Investigator's

More information

University of Oklahoma Office of Human Research Participant Protection SOP: 801 INVESTIGATOR QUALIFICATIONS AND RESPONSIBILITIES

University of Oklahoma Office of Human Research Participant Protection SOP: 801 INVESTIGATOR QUALIFICATIONS AND RESPONSIBILITIES 1. POLICY SOP: 801 INVESTIGATOR QUALIFICATIONS AND RESPONSIBILITIES The purpose of this policy is to outline the qualifications and responsibilities of the principal investigator and key personnel who

More information

Principal Investigator and Sub Investigator Responsibilities

Principal Investigator and Sub Investigator Responsibilities Principal Investigator and Sub Investigator Responsibilities I. Purpose To define the roles and responsibilities of Principal Investigators conducting research at GRU. II. Definition The term Principal

More information

Study Start-Up SS-204.01. STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV)

Study Start-Up SS-204.01. STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV) Study Start-Up SS-204.01 STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV) Approval: Nancy Paris, MS, FACHE President and CEO 08 March 2012 (Signature and Date) Approval: Frederick M. Schnell,

More information

CNE Disclosures. To change this title, go to Notes Master

CNE Disclosures. To change this title, go to Notes Master CNE Disclosures Successful Completion: Participants must complete an evaluation form to receive a certificate of completion Contact Hours: 1 contact hour is available to those who meet the successful completion

More information

A Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky

A Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky A Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky I. Compliance with IRB and Applicable Federal Requirements A. Investigators

More information

The Study Site Master File and Essential Documents

The Study Site Master File and Essential Documents The Study Site Master File and Essential Documents Standard Operating Procedure Office of Health and Medical Research Queensland Health SOP reference: 002 Version number: 1 Effective date: 01 June 2010

More information

Human Research Protection Program Good Clinical Practice Guidance for Investigators Investigator & Research Staff Responsibilities

Human Research Protection Program Good Clinical Practice Guidance for Investigators Investigator & Research Staff Responsibilities This Guidance Document is to ensure that investigators and research personnel recognize their responsibilities associated with the conduct of human subject research by outlining their responsibilities,

More information

Investigator Responsibilities

Investigator Responsibilities Investigator Responsibilities Standard Operating Procedure Office of Health and Medical Research Queensland Health SOP reference: 010 Version number: 1 Effective date: 01 June 2010 Review due: May 2011

More information

Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health

Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health We are responsible for acquiring, analyzing, and protecting medical information vital to providing quality patient care HIM professionals ensure

More information

Investigator responsibilities for research conducted under the authority of the UTHSCSA Institutional Review Board (IRB)

Investigator responsibilities for research conducted under the authority of the UTHSCSA Institutional Review Board (IRB) March 1, 2006 M E M O R A N D U M F O R R E C O R D TO: FROM: SUBJECT: Deans Department Chairs Principal Investigators Brian Herman, Ph.D. Vice President for Research Investigator responsibilities for

More information

STANDARD OPERATING PROCEDURES FOR GOOD CLINICAL PRACTICE

STANDARD OPERATING PROCEDURES FOR GOOD CLINICAL PRACTICE STANDARD OPERATING PROCEDURES FOR GOOD CLINICAL PRACTICE UNC OB/GYN (V.1) 9.1.2014 Page i TABLE OF CONTENTS INTRODUCTION. iii ABBREVIATIONS iv GLOSSARY v LISTING OF ATTACHMENTS.... xi I. 1.0 GENERAL ADMINISTRATION

More information

Subject: No. Page PROTOCOL AND CASE REPORT FORM DEVELOPMENT AND REVIEW Standard Operating Procedure

Subject: No. Page PROTOCOL AND CASE REPORT FORM DEVELOPMENT AND REVIEW Standard Operating Procedure 703 1 of 11 POLICY The Beaumont Research Coordinating Center (BRCC) will provide advice to clinical trial investigators on protocol development, content and format. Upon request, the BRCC will review a

More information

Guidance for Industry Investigator Responsibilities Protecting the Rights, Safety, and Welfare of Study Subjects

Guidance for Industry Investigator Responsibilities Protecting the Rights, Safety, and Welfare of Study Subjects Guidance for Industry Investigator Responsibilities Protecting the Rights, Safety, and Welfare of Study Subjects U.S. Department of Health and Human Services Food and Drug Administration Center for Drug

More information

ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS

ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES:

More information

Principal Investigator Responsibilities for Education and Social/Behavioral Researchers

Principal Investigator Responsibilities for Education and Social/Behavioral Researchers Principal Investigator Responsibilities for Education and Social/Behavioral Researchers Introduction The purpose of this module is to provide a basic understanding of the responsibilities of the principal

More information

Medical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11

Medical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11 Effective Date: 09/12/06, 08/02/10, 3/2/11 Title: 1.0 OBJECTIVE: 1.1 This SOP describes the methods and policies for: Handling investigational drug Dispensing investigational drug 1.2. This procedure applies

More information

Data Management Unit Research Institute for Health Sciences, Chiang Mai University

Data Management Unit Research Institute for Health Sciences, Chiang Mai University Data Management Unit Research Institute for Health Sciences, Chiang Mai University Clinical Data Management is the process of handling data from clinical trials. The inherent goal of any clinical data

More information

Clinical Trial Protocol Development. Developed by Center for Cancer Research, National Cancer Institute Endorsed by the CTN SIG Leadership Group

Clinical Trial Protocol Development. Developed by Center for Cancer Research, National Cancer Institute Endorsed by the CTN SIG Leadership Group Clinical Trial Protocol Development Developed by Center for Cancer Research, National Cancer Institute Endorsed by the CTN SIG Leadership Group Objectives The clinical trial protocol is the heart of any

More information

Friday, May 2. Clinical Trials: Is Your Staff Competent? Session 10:15 11:45 am Ballroom C

Friday, May 2. Clinical Trials: Is Your Staff Competent? Session 10:15 11:45 am Ballroom C Session 10:15 11:45 am Ballroom C Clinical Trials: Is Your Staff Competent? What fundamental skills and knowledge should clinical trials nurses have? In response to questions from its members about how

More information

Investigational Drugs: Investigational Drugs and Biologics

Investigational Drugs: Investigational Drugs and Biologics : I. PURPOSE The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics to ensure that adequate safeguards are in place

More information

Data Management & Case Report Form Development in Clinical Trials. Introduction to the Principles and Practice of Clinical Research.

Data Management & Case Report Form Development in Clinical Trials. Introduction to the Principles and Practice of Clinical Research. Data Management & Case Report Form Development in Clinical Trials Introduction to the Principles and Practice of Clinical Research February 3, 2015 Marge Good, RN, MPH, OCN Nurse Consultant Division of

More information

Investigator Responsibilities in Clinical Research: Insights and helpful hints for researchers

Investigator Responsibilities in Clinical Research: Insights and helpful hints for researchers Investigator Responsibilities in Clinical Research: Insights and helpful hints for researchers ITHS Clinical Research Education Series September 7, 2010 Objectives Understanding the requirements of DHHS

More information

Managing Data in Clinical Research. Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group

Managing Data in Clinical Research. Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Managing Data in Clinical Research Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Objectives Clinical data management (CDM) is a multidisciplinary

More information

CLINICAL RESEARCH ROLES CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES

CLINICAL RESEARCH ROLES CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES 1. Clinical Study Team Principal Investigator Co Principal Investigator (Co PI) Research Coordinator Study Monitor Data manage Sponsor Post Doctoral Scholar

More information

Site Initiation and Close Out (Sponsored Clinical Trials)

Site Initiation and Close Out (Sponsored Clinical Trials) Site Initiation and Close Out (Sponsored Clinical Trials) Standard Operating Procedure Office of Health and Medical Research Queensland Health SOP reference: 008 Version number: 1 Effective date: 01 June

More information

Research Institute Administration

Research Institute Administration PROTOCOL DEVIATIONS 229 1 of 7 PURPOSE The purpose of this policy is to define protocol deviations and the subsequent actions required by the Principal Investigator (PI) once a protocol deviation occurs

More information

INTERIM SITE MONITORING PROCEDURE

INTERIM SITE MONITORING PROCEDURE INTERIM SITE MONITORING PROCEDURE 1. PURPOSE The purpose of this SOP is to describe the interim monitoring procedures conducted at Institution, according to GCP and other applicable local regulations.

More information

Data Management DM STANDARD OPERATING PROCEDURE FOR Data Management

Data Management DM STANDARD OPERATING PROCEDURE FOR Data Management Data Management DM 401.00 STANDARD OPERATING PROCEDURE FOR Data Management Approval: Nancy Paris, MS, FACHE President and CEO 08 March 2012 (Signature and Date) Approval: Frederick M. Schnell, MD, FACP

More information

Clinical Investigator Training Course

Clinical Investigator Training Course Clinical Investigator Training Course Investigator Responsibilities in Biomedical Research Covered by FDA Regulations Lisa Zimmerman Objectives Discuss Clinical Investigator Obligations according to FDA

More information

Data Management and Good Clinical Practice Patrick Murphy, Research Informatics, Family Health International

Data Management and Good Clinical Practice Patrick Murphy, Research Informatics, Family Health International Data Management and Good Clinical Practice Patrick Murphy,, Family Health International 1 What is GCP? Good Clinical Practice is an international ethical and scientific quality standard for designing,

More information

Quality Monitoring Checklist

Quality Monitoring Checklist Quality Monitoring Checklist Instructions: For each task below, the Quality Monitor indicates in the appropriate column if the Monitor accomplished the task by using the following codes Yes No N/A = Monitor

More information

Information Sheet Guidance for Sponsors, Clinical Investigators, and IRBs

Information Sheet Guidance for Sponsors, Clinical Investigators, and IRBs Information Sheet Guidance for Sponsors, Clinical Investigators, and IRBs Frequently Asked Questions Statement of Investigator (Form FDA 1572) U.S. Department of Health and Human Services Food and Drug

More information

Adventist HealthCare, Inc.

Adventist HealthCare, Inc. IRB POLICY ON HUMAN RESEARCH PROTECTION (HRP) AND GOOD CLINICAL PRACTICE (GCP) TRAINING Collaborative Institutional Training Initiative (CITI) Requirements at Adventist Healthcare, Inc. I. Required Human

More information

The Monitoring Visit. Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis

The Monitoring Visit. Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis The Monitoring Visit Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis Disclosure The information herein is not intended to

More information

No. 706. Page 1 of 5. Issue Date 4/21/2014

No. 706. Page 1 of 5. Issue Date 4/21/2014 Subject: ROUTINE MONITORING VISITS Standard Operating Procedure Prepared By: Beaumont Research Coordinating Center, Research Institute PURPOSE Prior Issue Date 8/15/2011 No. 706 Issue Date 4/21/2014 Page

More information

This unit will provide the structure needed to achieve successful supervision and oversight of the study. We will explain the importance of an

This unit will provide the structure needed to achieve successful supervision and oversight of the study. We will explain the importance of an Music No audio Please review information shown to understand the general course navigation and available resources. Resources, such as the audio script, example forms, and website links, can be accessed

More information

DHHS/NIH/OD/OIR/OHSRP 1/2/2015

DHHS/NIH/OD/OIR/OHSRP 1/2/2015 DHHS/NIH/OD/OIR/OHSRP 1/2/2015 The audience for this course is Principal Investigators (PIs), investigators and Research Coordinators (RCs) serving on the study team of human clinical studies and trials.

More information

Objectives. Monitoring & Auditing of Clinical Trials. Overview. Pre-study Qualification Visit. Industry-sponsored Trials

Objectives. Monitoring & Auditing of Clinical Trials. Overview. Pre-study Qualification Visit. Industry-sponsored Trials Objectives Monitoring & Auditing of Clinical Trials Sponsored by Center for Cancer Research National Cancer Institute Guidelines suggest that following the good clinical research practice of monitoring/auditing

More information

The Clinical Trial Protocol Guide. BioStrategics Consulting Ltd.

The Clinical Trial Protocol Guide. BioStrategics Consulting Ltd. The Clinical Trial Protocol Guide 2011 BioStrategics Consulting Ltd. BioStrategics Consulting Ltd THE CLINICAL TRIAL PROTOCOL The clinical trial protocol to test one s product, to confirm or reject a specific

More information

AAHRPP Standards. Investigator Responsibilities for Research Involving Human Subjects

AAHRPP Standards. Investigator Responsibilities for Research Involving Human Subjects AAHRPP Standards Investigator Responsibilities for Research Involving Human Subjects Regulatory Landscape 2 AAHRPP OHRP FDA Pennington Louisiana Laws The Association for the Accreditation of Human Research

More information

Post-Approval Compliance Monitoring: A Responsibility of the Human Research Protection Program (but how to do it?)

Post-Approval Compliance Monitoring: A Responsibility of the Human Research Protection Program (but how to do it?) Post-Approval Compliance Monitoring: A Responsibility of the Human Research Protection Program (but how to do it?) Monika S. Markowitz, PhD Director, Office of Education and Compliance Oversight Office

More information

Data Management in Clinical Trials

Data Management in Clinical Trials Data Management in Clinical Trials Introduction to the Principles and Practice of Clinical Research February 19, 2013 Diane St. Germain, RN, MS Nurse Consultant Division of Cancer Prevention National Cancer

More information

Monitoring & Auditing of Clinical Trials. Sponsored by Center for Cancer Research National Cancer Institute

Monitoring & Auditing of Clinical Trials. Sponsored by Center for Cancer Research National Cancer Institute Monitoring & Auditing of Clinical Trials Sponsored by Center for Cancer Research National Cancer Institute Objectives Guidelines suggest that following the good clinical research practice of monitoring/auditing

More information

Clinical Trial Oversight: Ensuring GCP Compliance, Patient Safety and Data Integrity

Clinical Trial Oversight: Ensuring GCP Compliance, Patient Safety and Data Integrity Clinical Trial Oversight: Ensuring GCP Compliance, Patient Safety and Data Integrity Michelle Quaye Regulatory Manager, Advanced Therapy Trials University College London Overview The Principles of Good

More information

ROLE OF THE RESEARCH COORDINATOR Study Start-up Best Practices

ROLE OF THE RESEARCH COORDINATOR Study Start-up Best Practices Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Welcome to Online Training for Clinical Research Coordinators ROLE OF THE RESEARCH COORDINATOR Study Start-up

More information

CLINICAL RESEARCH HANDBOOK (2008 edition)

CLINICAL RESEARCH HANDBOOK (2008 edition) CLINICAL RESEARCH HANDBOOK (2008 edition) This Handbook was written with the intent of aiding researchers at the Ochsner Clinic Foundation through the clinical research process. This handbook does not

More information

Essential Documents for the Conduct of a Clinical Trial. Debra Dykhuis Associate Director RSO

Essential Documents for the Conduct of a Clinical Trial. Debra Dykhuis Associate Director RSO Essential Documents for the Conduct of a Clinical Trial Debra Dykhuis Associate Director RSO Introduction Rationale for choosing this topic AHC movement toward setting GCP (Good Clinical Practice) guidelines

More information

The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial

The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial Clinical Research Operations & Regulatory Support (CRORS) Ann Glasse, RN, BSN, MBA Director-CRORS Objectives

More information

Tool Summary Sheet. Tool: Extramural Essential Documents Binder/File Tabs

Tool Summary Sheet. Tool: Extramural Essential Documents Binder/File Tabs Tool Summary Sheet Tool: Extramural Essential Documents Binder/File Tabs Purpose: To provide an organizational framework and guidance for filing paper versions of essential study documents (or referencing

More information

Orientation Manual for Clinical Research Coordinators

Orientation Manual for Clinical Research Coordinators Orientation Manual for Clinical Research Coordinators Maine Medical Center Research Institute Page 1 of 19 Version 1 (2009) MAINE MEDICAL CENTER RESEARCH INSTITUTE Statement of Mission, Vision, Goals and

More information

History and Principles of Good Clinical Practice

History and Principles of Good Clinical Practice History and Principles of Good Clinical Practice Cristina E. Torres, Ph.D. Social Science Professor, UPM-NIH FERCAP Coordinator ICH: International Conference on Harmonization GCP: Good Clinical Practices

More information

FDA Audit Guidelines. University of Miami. Office of the Vice Provost for Research

FDA Audit Guidelines. University of Miami. Office of the Vice Provost for Research FDA Audit Guidelines University of Miami Office of the Vice Provost for Research FDA Audit Guidelines Contents INTRODUCTION 3 VICE PROVOST FOR RESEARCH ROLE IN FDA AUDITS 3 PRE-AUDIT REVIEW 3 INSPECTION

More information

UNIVERSITY OF CALIFORNIA, SAN DIEGO HUMAN RESEARCH PROTECTIONS PROGRAM. DoD/DON-funded Research

UNIVERSITY OF CALIFORNIA, SAN DIEGO HUMAN RESEARCH PROTECTIONS PROGRAM. DoD/DON-funded Research UNIVERSITY OF CALIFORNIA, SAN DIEGO HUMAN RESEARCH PROTECTIONS PROGRAM DoD/DON-funded Research Policy In 2006, the Department of the Navy (DON) enhanced its human subject protection requirements, including

More information

IRB Submissions and Human Subjects Research Compliance. Georgia Health Sciences University

IRB Submissions and Human Subjects Research Compliance. Georgia Health Sciences University IRB Submissions and Human Subjects Research Compliance Offi f H R hp t ti Office of Human Research Protection Georgia Health Sciences University Objectives Identify the steps required to submit a protocol

More information

Public Policy Statement: Clinical Trial Ethics

Public Policy Statement: Clinical Trial Ethics Public Policy Statement: Clinical Trial Ethics Purpose As a global healthcare company, Merck's role is first and foremost to discover, develop and provide innovative products and services that save and

More information

Health Care Job Information Sheet #20. Clinical Research

Health Care Job Information Sheet #20. Clinical Research Health Care Job Information Sheet #20 Clinical Research A. Background B. Occupations 1) Clinical Research Associate (Study Monitor) 2) Clinical Research Coordinator 3) Other positions in the field C. Labour

More information

The Ontario Cancer Research Ethics Board Overview

The Ontario Cancer Research Ethics Board Overview The Ontario Cancer Research Ethics Board Overview Research Ethics Research ethics review is vital to the advancement of ethically sound research. Before individuals can be enrolled in a research study,

More information

Comprehensive Study Documents List (Biomedical Studies)

Comprehensive Study Documents List (Biomedical Studies) Comprehensive Study Documents List (Biomedical Studies) Investigators conducting human subjects research must maintain study documents in adherence to federal and state regulations, USC policies, and good

More information

ROLE OF THE RESEARCH COORDINATOR

ROLE OF THE RESEARCH COORDINATOR Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Welcome to Online Training for Clinical Research Coordinators ROLE OF THE RESEARCH COORDINATOR Data Collection

More information

Vertex Investigator-Initiated Studies Program Overview

Vertex Investigator-Initiated Studies Program Overview Vertex Investigator-Initiated Studies Program Overview Our Goal To support independent, investigator-initiated research designed to advance scientific knowledge of disease states, patient populations,

More information

Laurie Shaker-Irwin, Ph.D., M.S. Co-Leader, Regulatory Knowledge and Research Ethics UCLA Clinical and Translational Science Institute

Laurie Shaker-Irwin, Ph.D., M.S. Co-Leader, Regulatory Knowledge and Research Ethics UCLA Clinical and Translational Science Institute Laurie Shaker-Irwin, Ph.D., M.S. Co-Leader, Regulatory Knowledge and Research Ethics UCLA Clinical and Translational Science Institute Understand the protocol completely Recognize institutional polices

More information

Yale Cancer Center Data and Safety Monitoring Committee Charter

Yale Cancer Center Data and Safety Monitoring Committee Charter Yale Cancer Center Data and Safety Monitoring Committee Charter Purpose/Mission The purpose of the Yale Cancer Center (YCC) Data and Safety Monitoring Committee (DSMC) is to provide ongoing data and safety

More information

U.S. Food and Drug Administration

U.S. Food and Drug Administration U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA s website for reference purposes only. It was current when produced, but is no longer maintained

More information

Catherine Jahrsdorfer, RN, BSN Director of Clinical Services USF Health Office of Clinical Research

Catherine Jahrsdorfer, RN, BSN Director of Clinical Services USF Health Office of Clinical Research A Practical Guide on Applying USF HRPP P&Ps in the Clinical Setting Catherine Jahrsdorfer, RN, BSN Director of Clinical Services USF Health Office of Clinical Research Learning Objectives Recognize the

More information

The Role of the Clinical Trials Nurse. Objectives. CTN: Protocol Development

The Role of the Clinical Trials Nurse. Objectives. CTN: Protocol Development The Role of the Clinical Trials Nurse Elizabeth Ness, RN, MS Director, Staff Development Center for Cancer Research, NCI Objectives Discuss the clinical trials nurse s involvement in protocol development.

More information

Introduction 2. 1. The Role of Pharmacy Within a NHS Trust 3. 2. Pharmacy Staff 4. 3. Pharmacy Facilities 5. 4. Pharmacy and Resources 6

Introduction 2. 1. The Role of Pharmacy Within a NHS Trust 3. 2. Pharmacy Staff 4. 3. Pharmacy Facilities 5. 4. Pharmacy and Resources 6 Index Index Section Page Introduction 2 1. The Role of Pharmacy Within a NHS Trust 3 2. Pharmacy Staff 4 3. Pharmacy Facilities 5 4. Pharmacy and Resources 6 5. Prescription Charges 7 6. Communication

More information

INVESTIGATOR HANDBOOK

INVESTIGATOR HANDBOOK INVESTIGATOR HANDBOOK Liberty IRB, Inc. 1450 S. Woodland Blvd., Suite 300A Deland, Florida 32720 Phone (386) 279-4318 Fax: (386)868-4563 Website: www.libertyirb.com Business hours: Monday Friday, 8:00am

More information

This policy applies to all clinical research conducted at Beaumont Health System.

This policy applies to all clinical research conducted at Beaumont Health System. CLINICAL RESEARCH QUALITY AND PROCESS IMPROVEMENT PROGRAM 113 1 of 6 PURPOSE Prior The purpose of this policy is to provide an overview of the Clinical Research Quality and Process Improvement Program

More information

RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING

RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING July 2006 TABLE OF CONTENTS Page 1. Introduction 2 2. Scope 2 3. Documents to be archived 2 4. Quality of essential documents 10 5.

More information

CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE]

CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE] CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE] CONTRACT RESEARCH ORGANIZATION SPONSOR [NAME] [ADDRESS] 1 TABLE OF CONTENTS 1. Purpose 3 2. References 3 3. Study Roles and Responsibilities

More information

MINNEAPOLIS MEDICAL RESEARCH FOUNDATION CLINICAL RESEARCH STANDARD OPERATING PROCEDURES TABLE OF CONTENTS

MINNEAPOLIS MEDICAL RESEARCH FOUNDATION CLINICAL RESEARCH STANDARD OPERATING PROCEDURES TABLE OF CONTENTS MINNEAPOLIS MEDICAL RESEARCH FOUNDATION CLINICAL RESEARCH STANDARD OPERATING PROCEDURES TABLE OF CONTENTS CATEGORY SOP # Clinical Research: Administrative Standard Operating Procedures (SOPs) 1.1 Outreach

More information

Good Clinical Practice 101: An Introduction

Good Clinical Practice 101: An Introduction Good Clinical Practice 101: An Introduction Presented by: Lester Jao Lacorte, MD Medical Officer Commissioner s Fellow Division of Bioresearch Monitoring Office of Compliance Center for Devices and Radiological

More information

To Certify or Not to Certify

To Certify or Not to Certify To Certify or Not to Certify Sandra Halvorson, BA, CCRP Clinical Research Coordinator II CIBMTR Minneapolis Campus Sue Logan, BS, CCRP Clinical Research Coordinator II CIBMTR Minneapolis Campus November

More information

To Certify or Not to Certify Sandra Halvorson, BA, CCRP

To Certify or Not to Certify Sandra Halvorson, BA, CCRP To Certify or Not to Certify Sandra Halvorson, BA, CCRP Clinical Research Coordinator II CIBMTR Minneapolis Campus Sue Logan, BS, CCRP Clinical Research Coordinator II We have no financial relationships

More information

CLINICAL RESEARCH PROTOCOL CHECKLIST

CLINICAL RESEARCH PROTOCOL CHECKLIST CLINICAL RESEARCH PROTOCOL CHECKLIST [taken from ICH GCP : Guidance for Industry, Good Clinical Practice: Consolidated Guidance, Revision 1 (R1) June 1996] ICH GCP, Section 6. CLINICAL TRIAL PROTOCOL AND

More information

Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: shjohnson@email.com

Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: shjohnson@email.com SAMPLE CRA CV Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: shjohnson@email.com Education: Masters of Science, Healthcare Administration, Capital City University,

More information

Disclaimer. Objectives 5/30/2016

Disclaimer. Objectives 5/30/2016 Good Clinical Practice Informed Consent Training Presented by Jacqueline Everett Clinical Trial Governance Manager, Research Integrity Disclaimer The material in this presentation has been prepared by

More information

Guidance on IRB Continuing Review of Research

Guidance on IRB Continuing Review of Research NOTE: THIS GUIDANCE SUPERSEDES OHRP S JANUARY 15, 2007 GUIDANCE ENTITILED GUIDANCE ON CONTINUING REVIEW. CLICK HERE FOR THE JANUARY 15, 2007 GUIDANCE. Office for Human Research Protections Department of

More information

TRIAL MASTER FILE- SPONSORED

TRIAL MASTER FILE- SPONSORED gsop-06-04 - Management of TMF for ENHT/ WHHT Sponsored CTIMPs Page 1 of 16 Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust TRIAL MASTER

More information

Health Canada s GCP Compliance Program. GCP Information Sessions November 2010

Health Canada s GCP Compliance Program. GCP Information Sessions November 2010 Your Health and Safety... Our priority Votre santé et votre Securité notre priorité Health Canada s GCP Compliance Program GCP Information Sessions November 2010 Objective To describe the role that Health

More information

Global Policy on Interactions with Healthcare Professionals

Global Policy on Interactions with Healthcare Professionals Global Policy on Interactions with Healthcare Professionals Global Policy on Interactions with Healthcare Professionals Pfizer is committed to collaborating with physicians and other healthcare professionals,

More information

University of Hawai i Human Studies Program. Guidelines for Developing a Clinical Research Protocol

University of Hawai i Human Studies Program. Guidelines for Developing a Clinical Research Protocol University of Hawai i Human Studies Program Guidelines for Developing a Clinical Research Protocol Following are guidelines for writing a clinical research protocol for submission to the University of

More information

Adverse Events: Documenting, Recording, and Reporting

Adverse Events: Documenting, Recording, and Reporting Adverse Events: Documenting, Recording, and Reporting Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Introduction Monitoring of adverse

More information

Human Subjects Research (HSR) Series

Human Subjects Research (HSR) Series Human Subjects Research (HSR) Series CITI Program s HSR series consists of modules from two basic tracks, Biomedical (Biomed) and Social- Behavioral- Educational (SBE), and a set of Additional Modules

More information

Reliance Agreement for Institutions Utilizing Stony Brook University s Institutional Review Board(s)

Reliance Agreement for Institutions Utilizing Stony Brook University s Institutional Review Board(s) Name of Organization Providing IRB Review: Stony Brook University ( SBU IRB ) Name of Institution Relying on the SBU IRB ( Institution ): Latest AAHRPP Accreditation Date (if applicable) OHRP Federal Wide

More information

Guidance for Industry E6 Good Clinical Practice: Consolidated Guidance

Guidance for Industry E6 Good Clinical Practice: Consolidated Guidance Guidance for Industry E6 Good Clinical Practice: Consolidated Guidance ICH April 1996 Guidance for Industry E6 Good Clinical Practice: Consolidated Guidance Additional copies are available from: the Drug

More information

Core Training Outline

Core Training Outline Core Training Outline Modules: 1) Study Design 2) PI Oversight 3) Financial Management 4) Study Operations 5) Recruitment & Retention 6) Informed Consent 7) Investigational Products 8) Subject Safety 9)

More information

Guidance for Industry and FDA Staff FDA Acceptance of Foreign Clinical Studies Not Conducted Under an IND Frequently Asked Questions

Guidance for Industry and FDA Staff FDA Acceptance of Foreign Clinical Studies Not Conducted Under an IND Frequently Asked Questions Guidance for Industry and FDA Staff FDA Acceptance of Foreign Clinical Studies Not Conducted Under an IND Frequently Asked Questions U.S. Department of Health and Human Services Food and Drug Administration

More information

Guidelines for preparing Standard Operating Procedures (SOP) for Institutional Ethics Committee for Human Research

Guidelines for preparing Standard Operating Procedures (SOP) for Institutional Ethics Committee for Human Research Guidelines for preparing Standard Operating Procedures (SOP) for Institutional Ethics Committee for Human Research 1. Objective: The objective of this SOP is to contribute to the effective functioning

More information

Role of IRB/IEC in GCP. Benjamin Kuo, MD, Dr.PH, CIP.

Role of IRB/IEC in GCP. Benjamin Kuo, MD, Dr.PH, CIP. Role of IRB/IEC in GCP Benjamin Kuo, MD, Dr.PH, CIP. Institutional Review Board (IRB) An independent body constituted of medical, scientific and non scientific members Responsible for ensuring protection

More information

The role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations

The role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations The role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations Maria Luisa Paoloni OPBG Clinical & Research Services Monitoring and Responsible of monitoring:

More information

A clinical research organization

A clinical research organization A clinical research organization About Us State of art facility. All clinical trials carried out in accordance with ICH GCP guidelines. Quality services within stipulated time period. Team of experienced

More information

Clinical Data Management. Sponsored by Center for Cancer Research National Cancer Institute

Clinical Data Management. Sponsored by Center for Cancer Research National Cancer Institute Clinical Data Management Sponsored by Center for Cancer Research National Cancer Institute Introduction Clinical data management (CDM) consists of various activities involving the handling of data or information

More information

Guide for Research Sites Seeking Accreditation

Guide for Research Sites Seeking Accreditation Guide for Research Sites Seeking Accreditation (For research sites that only conduct research and do not have their own IRBs) November 16, 2010 Purpose of the Guide The accreditation process for most research

More information

U.S. Food and Drug Administration

U.S. Food and Drug Administration U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA s website for reference purposes only. It was current when produced, but is no longer maintained

More information

SUBJECT: Principal Investigator Oversight POLICY: RA:HRPP:10.13

SUBJECT: Principal Investigator Oversight POLICY: RA:HRPP:10.13 SUBJECT: Principal Investigator Oversight POLICY: RA:HRPP:10.13 DATE EFFECTIVE: PAGE: 1 of 2 I. POLICY The Children s National Medical Center (CNMC) Human Research Protections Program (HRPP) recognizes

More information

GOOD CLINICAL PRACTICE*)

GOOD CLINICAL PRACTICE*) GOOD CLINICAL PRACTICE*) Guideline Title Good Clinical Practice*) Legislative basis Directive 75/318/EEC as amended Date of first adoption July 1990 This version July 1996 Date of entry into January 1997

More information